Synonyms: SGX523
Compound class:
Synthetic organic
Comment: SGX-523 is an ATP-competitive, highly selective inhibitor of the receptor tyrosine kinase, hepatocyte growth factor receptor (MET) [1] [2]. While Buchanan et al. [1] include three PDB structures linked via PubMed to MMDB entries, two of them depict a charge-state tautomer of SGX-523. These thus point to a different compound PubChem CID 42628064 but the PDB link above points to the correct ligand structure. Note also, becasue of its established specificity, this now has a SGC Probe Portal entry SGX-523.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Growth of xenograft tumours of human glioblastoma, lung and gastric cancers is inhibited by SGX-523, in a dose-dependent manner [1]. |
Selectivity at catalytic receptors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|